Merck to Request Approval for COVID-19 Drug

Fae Courter
By Fae Courter
October 1, 2021NTD Business
share

Pharmaceutical company Merck is requesting emergency use authorization for an experimental COVID-19 drug. It targets the CCP (Chinese Communist Partyvirus’s ability to make copies of itself.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.
Comments